東莨菪鹼市場：按劑型、通路、地區

預計2024年全球東莨菪鹼市場規模為4.851億美元，預計2031年將達到7.392億美元，2024年至2031年複合年成長率為6.2%。

圖 1. 2024 年東莨菪鹼市場佔有率(%)，依地區分類

東莨菪鹼是一種常用於控制暈動病和噁心的藥物化合物。由於娛樂性藥物的使用增加和許多最終用途行業的應用增加等因素，全球東莨菪鹼市場在過去幾年中穩步成長。東莨菪鹼主要從茄科植物中提取，其中曼陀羅或曼陀羅是主要的商業性來源。它作為腦幹和中樞神經系統其他部分的毒蕈鹼乙醯膽鹼受體的競爭性拮抗劑，阻斷來自前庭系統的影響平衡和運動感知的訊號。它有多種劑型，包括錠劑、貼片和注射劑，可有效控制暈動病、術後噁心和嘔吐以及與癌症化療相關的噁心等症狀。

市場動態：

海上和空中旅行的增加、止吐藥消費量的增加以及東莨菪鹼貼劑用於術後護理的臨床使用的增加可能會推動全球東莨菪鹼市場的成長。然而，與過量服用相關的副作用以及從植物來源中提取生物鹼的規定可能會阻礙市場成長。繼續研究和開發新的蓋倫製劑、專注於聯合治療以及評估新的治療應用可能會為市場相關人員提供機會。原物料價格的波動也會影響市場參與企業的供應和定價策略。

本研究的主要特點

• 本報告對全球東莨菪鹼市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
• 它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
• 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球東莨菪鹼市場的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球東莨菪鹼市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過用於全球東莨菪鹼市場分析的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行概述
• 一致的機會地圖 (COM)

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球東莨菪鹼市場－冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章全球東莨菪鹼市場，按劑型，2019-2031，（百萬美元）

• 介紹
• 錠劑
• 糖漿
• 注射
• 修補
• 其他

第6章 全球東莨菪鹼市場，依通路分類，2019-2031 年（百萬美元）

• 介紹
• 醫院藥房
• 零售藥房
• 網路藥房

第7章全球東莨菪鹼市場，按地區，2019-2031，（百萬美元）

• 介紹
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第8章 競爭格局

• 公司簡介
  • Alchem International
  • Integra LifeSciences Holding Corporation
  • Alkaloids Corporation
  • Boehringer Ingelheim
  • Caleb Pharmaceuticals, Inc.
  • Centroflora Group
  • Fine Chemicals Corporation
  • GlaxoSmithKline plc
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Laboratorio RAAM de Sahuayo
  • Mylan NV（part of Viatris）
  • Novartis AG
  • Pfizer Inc.
  • Pharmaceutical Associates, Inc.
  • Phytex Australia
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Global Alkaloids

第9章 分析師建議

• 升起和降落
• 綜合機會圖

第10章 參考文獻與調查方法

• 參考
• 調查方法

Global scopolamine market is estimated to be valued at USD 485.1 Mn in 2024 and is expected to reach USD 739.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

Figure 1. Scopolamine Market Share (%), By Region, 2024

Scopolamine is a pharmaceutical compound that is commonly used to curb motion sickness and nausea. Global scopolamine market has witnessed steady growth over the past few due to factors such as increasing recreational drug usage and rising application across numerous end-use industries. Scopolamine is predominantly extracted from plants belonging to the Solanaceae family of which Datura stramonium or Jimson weed is the major commercial source. It acts as a competitive antagonist of muscarinic acetylcholine receptors in the brainstem and other parts of the central nervous system to block signals from the vestibular system affecting balance and motion perception. The drug is available in various dosage forms including tablets, patches, and injections to effectively manage symptoms of motion sickness, post-operative nausea & vomiting, and nausea associated with cancer chemotherapy.

Market Dynamics:

Rising sea and air travel, increasing consumption of antiemetic drugs, and growing clinical use of scopolamine patches for postoperative care can drive the global scopolamine market growth. However, adverse effects associated with overdosage and restrictions on plant-derived alkaloids extraction can hamper the market growth. Ongoing R&D to develop new galenic formulations, focus on combination therapies, and evaluation of additional therapeutic applications can offer opportunities for market players. Fluctuating prices of raw materials also impact the supply and pricing strategies adopted by different market participants.

Key Features of the Study:

• This report provides in-depth analysis of the global scopolamine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global scopolamine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer, Baxter, Caleb Pharmaceuticals, Alkaloids of Australia.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine market.

Detailed Segmentation-

• By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Alchem International
  • Integra LifeSciences Holding Corporation
  • Alkaloids Corporation
  • Boehringer Ingelheim
  • Caleb Pharmaceuticals, Inc.
  • Centroflora Group
  • Fine Chemicals Corporation
  • GlaxoSmithKline plc
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Laboratorio RAAM de Sahuayo
  • Mylan N.V. (part of Viatris)
  • Novartis AG
  • Pfizer Inc.
  • Pharmaceutical Associates, Inc.
  • Phytex Australia
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Global Alkaloids

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Scopolamine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Scopolamine Market, By Dosage Form, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Tablet
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Syrup
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Patch
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Scopolamine Market, By Distribution Channel, 2019 - 2031, (USD Mn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Scopolamine Market, By Region, 2019 - 2031, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Alchem International
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integra LifeSciences Holding Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alkaloids Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Caleb Pharmaceuticals, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Centroflora Group
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fine Chemicals Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline plc
  • Henan Fusen Pharmaceutical Co., Ltd.
  • Laboratorio RAAM de Sahuayo
  • Mylan N.V. (part of Viatris)
  • Novartis AG
  • Pfizer Inc.
  • Pharmaceutical Associates, Inc.
  • Phytex Australia
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Global Alkaloids

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact